Company

ONL Therapeutics

https://onltherapeutics.com/

Industryclinical-stage biopharmaceutical company focused on advancing treatments of geographic atrophy (GA) associated with dry age-related macular degeneration (AMD)

Funding raised

CompanyRoundDate
ONL TherapeuticsSeries D Financing2024-09-16